Nexus Concordat. Gold dragon in a hexagonal frame beside the wordmark.
Nexus Concordat Inc. · Overview · 22 June 2026

Where everything connects.

A single hub for Nexus Concordat Inc. The patents on file, the operating company built on them, the IP holding page, the technical artifacts, the lore universe that became the testbed. Each link below opens the relevant document or live system.

4 USPTO provisionals pending Cardiac specialist cell live psych_gen1 in training Mayo Waypoints Program · Sept 2026 cycle Delaware C-Corp · File 10605960

The four pending patents

63/939,190
Substrate-Independent Memory Weighting
Pharmacokinetic decay applied as attention mechanism. Internal state with biologically meaningful half-lives.
63/962,385
Neurochemical Language Model
The 34-head cascade architecture. Five-molecule rate equations as the first layer of state.
63/988,485
Cell-as-Opcode Tree
Architectural unification of model, tools, and biological cell metaphor as a hash-verifiable composition.
64/034,536
Hash-Verifiable Specialist Composition
Merkle DAG of cells with signed inference manifest emission. The verifiability layer.

Where to look

Each card below opens a different surface. Reviewers can follow any of them independently.

Who is on the work

Marjorie McCubbins, BSc. Founder and Chair. Biochemist and Molecular Biologist. Inventor of record on all four pending patent applications. Built every layer of the architecture.

Jason Alba, MBA, DBA. Director, Business Strategy & Governance. Founder of EvoSynapse AI. Twenty-plus years of pharma regulatory operations.

Robert Michalik, JD, RAC. Director, Regulatory Strategy. FDA Quality and Clinical SME. Twenty-five years of biopharma and medical device regulatory affairs. Found the work independently through LinkedIn in January 2026 and offered support before we met in person. Mutual NDA signed.

Aislinn McCubbins. COO, Dynamic Hallucination, Inc. (the operating company). Co-creator of canon architecture and lore systems.